Peter Kay Reveals Major Tour Update During The One Show Appearance

ago 8 days
Peter Kay Reveals Major Tour Update During The One Show Appearance

Peter Kay recently unveiled exciting news during his appearance on The One Show. The beloved comedian will expand his “Better Late Than Never” tour with additional dates set for next year.

Major Tour Update from Peter Kay

The 52-year-old, hailing from Bolton, launched his “Better Late Than Never” tour in 2022. The overwhelming success of the tour prompted Kay to announce that he will add final performances in 2026. This tour has broken numerous attendance records at the AO Arena, showcasing his enduring popularity.

Record-Breaking Performances

Notably, Peter Kay achieved a remarkable milestone by becoming the first artist to conduct a monthly residency at The O2 in London. He performed 45 shows, setting the record for the most performances by any artist in that venue’s history.

Charitable Endeavors

In a heartfelt move, all profits from the upcoming performances will be donated to twelve cancer charities. During the show, Kay emphasized the importance of supporting these causes. “Unfortunately, everyone knows someone affected by cancer,” he stated. “I just hope people will come support the shows, even if they don’t like me.”

  • Children with Cancer UK
  • Teenage Cancer Trust
  • Kidney Cancer UK
  • Blood Cancer UK
  • Bowel Cancer UK
  • Prostate UK
  • DKMS
  • Ovarian Cancer Action
  • Pancreatic Cancer UK
  • Anthony Nolan
  • The Brain Tumour Charity
  • Breast Cancer UK

Upcoming Ticket Sales

Tickets for the newly announced shows will go on sale on Sunday, November 30. The performances are scheduled to commence on March 8. Peter Kay’s commitment to both entertainment and charitable causes continues to resonate with fans and supporters alike.

“If it’s not funny, you get your money back… Just kidding!” Kay humorously reminded his audience. His light-hearted take highlights his dedication to making the experience enjoyable while raising funds for crucial cancer research and support.